The Straehla Lab, located at Seattle Children’s Research Institute, focuses on accelerating the translation of drug delivery technologies for cancer therapy, with a special emphasis on using nanomedicines in cancers. Led by Dr. Joelle Straehla, a pediatric oncologist specializing in brain and spinal cord tumors, the lab operates at the intersection of nanotechnology and cancer biology. The lab’s primary objectives include 1) Designing and synthesizing new nanoparticle-based therapeutics 2) Identifying biologic regulators of nanoparticle drug delivery 3) Improving the delivery of therapeutic agents across challenging tissue barriers and 4) Developing strategies to selectively remodel the tumor microenvironment. By bridging the gap between innovative engineering tools and clinical practice, the Straehla Lab aims to overcome drug delivery challenges and accelerate the implementation of nanomedicine in cancer treatment, particularly for pediatric patients. In the Straehla Lab, we celebrate diversity of thought and background, and welcome all types of learners.